BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 188551)

  • 41. Estrogen and prolactin receptor concentrations in rat mammary tumors and response to endocrine ablation.
    DeSombre ER; Kledzik G; Marshall S; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):354-8. PubMed ID: 177195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of insulin and estrogen on hormone binding in the R3230AC mammary adenocarcinoma.
    Shafie SM; Gibson SL; Hilf R
    Cancer Res; 1977 Dec; 37(12):4641-9. PubMed ID: 922744
    [No Abstract]   [Full Text] [Related]  

  • 44. Growth enhancement of N-nitrosomethylurea-induced rat mammary tumor cells in soft agar by estrogen or prolactin.
    Arafah BM; Griffin P; Gordon NH; Pearson OH
    Cancer Res; 1984 Dec; 44(12 Pt 1):5605-8. PubMed ID: 6498820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors.
    Leung BS; Sasaki GH; Leung JS
    Cancer Res; 1975 Mar; 35(3):621-7. PubMed ID: 163687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical characterization of carcinogen-induced mammary hyperplastic aveolar nodule and tumor in the rat.
    Dao TL; Chistakos SS; Varela R
    Cancer Res; 1975 May; 35(5):1128-34. PubMed ID: 164277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).
    Briand P
    Anticancer Res; 1983; 3(4):273-81. PubMed ID: 6309070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of mammary tumor growth by dexamethasone in rats in the presence of high serum prolactin levels.
    Aylsworth CF; Sylvester PW; Leung FC; Meites J
    Cancer Res; 1980 Jun; 40(6):1863-6. PubMed ID: 7371016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioreceptor assay for lactogenic hormones based on membranes from rat mammary tumour.
    Pahnke VG; Hoelzel F; Graesslin D; Bettendorf G
    Horm Metab Res; 1986 Oct; 18(10):680-5. PubMed ID: 3781474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice.
    Sinha YN; Salocks CB; VanderLaan WP
    Horm Metab Res; 1976 Sep; 8(5):332-6. PubMed ID: 989755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
    Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
    Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
    Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
    Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions between estrogens, prolactin, and growth hormone on the growth of N-nitrosomethylurea-induced rat mammary tumors.
    Rose DP; Gottardis M
    Anticancer Res; 1985; 5(4):397-402. PubMed ID: 4037735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship of hormones to inhibition of mammary tumor development by underfeeding during the "critical period" after carcinogen administration.
    Sylvester PW; Aylsworth CF; Meites J
    Cancer Res; 1981 Apr; 41(4):1384-8. PubMed ID: 6783295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steroid hormone receptors in MCCLX, a transplantable lactogen-dependent mammary tumor of the rat.
    Lewko WM; Kano-Sueoka T; Wittliff JL
    Horm Metab Res; 1985 Apr; 17(4):189-93. PubMed ID: 4007768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estradiol-dependent collagenolytic enzyme activity in long-term organ culture of human breast cancer.
    Heuson JC; Pasteels JL; Legros N; Heuson-Stiennon J; Leclercq G
    Cancer Res; 1975 Aug; 35(8):2039-48. PubMed ID: 167944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of lactogenic hormone binding in rat liver by steroid hormones.
    Sherman BM; Stagner JI; Zamudio R
    Endocrinology; 1977 Jan; 100(1):101-7. PubMed ID: 187403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolactin receptors in estrogen receptor-deficient mammary carcinoma.
    Costlow ME; Buschow RA; McGuire WL
    Science; 1974 Apr; 184(4132):85-6. PubMed ID: 4360955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vasopressin stimulation of acetate incorporation into lipids in a dimethylbenz(a)anthracene-induced rat mammary tumor cell line.
    Monaco ME; Lippmann ME; Knazek R; Kidwell WR
    Cancer Res; 1978 Nov; 38(11 Pt 2):4101-4. PubMed ID: 100217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.